Vitamin B12 deficiency is well known to result in symptoms similar to those that occur in multiple sclerosis. Significantly, therefore, an association between this neurological disease and low levels of vitamin B12 has been noted for more than 30 years now. Levels have been shown to be lower in patients who experience the onset of their symptoms prior to the age of 18.
In this latest study, scientists in the United States claim to have made a potential breakthrough in treating multiple sclerosis by discovering a molecular link between vitamin B12 and the condition. They therefore propose that, in addition to supplementation, the disease could be treated with drugs that increase levels of a specific receptor that is crucial for the nutrient’s uptake in the central nervous system.
Ultimately, of course, vitamin B12 is far from being the only nutrient that plays a key role in multiple sclerosis. In particular, evidence is mounting that a lack of vitamin D may increase the risk of developing the disorder. Other nutrients known to be important include coenzyme Q10 (CoQ10), biotin, lipoic acid, L-carnitine, polyunsaturated fatty acids and vitamin E.
To read a case report about the successful control of multiple sclerosis using Dr. Rath’s Cellular Medicine approach, see this article on our website.
Bringing Health and Hope to Zimbabwe through the Movement of Life
December 15, 2023Vitamin D Deficiency Linked to Inflammation in Inflammatory Bowel Disease Patients
January 11, 2024Vitamin B12 May Hold Key to Treating Multiple Sclerosis
News
Scientists have discovered a potential medical breakthrough in the treatment of multiple sclerosis (MS). Researchers from Sanford Burnham Prebys unveiled a remarkable molecular connection between vitamin B12 and MS, occurring within astrocytes, non-neuronal glial cells in the brain.
[Source: studyfinds.org]
[Image source: Adobe Stock]
Comment
Vitamin B12 deficiency is well known to result in symptoms similar to those that occur in multiple sclerosis. Significantly, therefore, an association between this neurological disease and low levels of vitamin B12 has been noted for more than 30 years now. Levels have been shown to be lower in patients who experience the onset of their symptoms prior to the age of 18.
In this latest study, scientists in the United States claim to have made a potential breakthrough in treating multiple sclerosis by discovering a molecular link between vitamin B12 and the condition. They therefore propose that, in addition to supplementation, the disease could be treated with drugs that increase levels of a specific receptor that is crucial for the nutrient’s uptake in the central nervous system.
Ultimately, of course, vitamin B12 is far from being the only nutrient that plays a key role in multiple sclerosis. In particular, evidence is mounting that a lack of vitamin D may increase the risk of developing the disorder. Other nutrients known to be important include coenzyme Q10 (CoQ10), biotin, lipoic acid, L-carnitine, polyunsaturated fatty acids and vitamin E.
To read a case report about the successful control of multiple sclerosis using Dr. Rath’s Cellular Medicine approach, see this article on our website.
Dr. Rath Health Foundation
Related posts
France Records Growing Number of Supercentenarians
Read more